AGP Executive Report
Last update: 2 hours agoHerbal & diet research: A pooled review of 29 randomized trials (1,583 people) links whole edible algae to modest blood-pressure drops, especially for those starting with higher readings. A separate long-term study following 179,508 people reports that sticking to plant-forward eating patterns (including the EAT-Lancet style) is associated with lower chronic kidney disease risk. Food & health tradeoffs: With the Strait of Hormuz effectively closed to shipping, researchers warn the resulting layups of 1,500+ vessels could spread marine biofouling species when traffic resumes—an indirect hit to fisheries and coastal health. China health policy signals: China’s CPI data show medical services prices rising while overall inflation cools, a reminder that healthcare costs remain a pressure point for households. Biotech & clinical pipeline: Akeso says it has dosed the first patient in a Phase II breast cancer study combining its TROP2/Nectin-4 bsADC with ivonescimab, aiming to expand options for hard-to-treat subtypes. Regulatory/industry watch: A US judge temporarily blocks the Pentagon from labeling WuXi AppTec as a “Chinese military company,” easing near-term compliance risk for a major life-sciences services firm.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
